drugset / Trial / NCT01235130

Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation

NCT01235130

Phase 3 Completed 337 enrolled Montreal Heart Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The general objective of this study is to demonstrate the effectiveness of n-3 fatty acids, 2.4 grams per day, to prevent recurrence of atrial fibrillation in patients with paroxysmal or persistent AF in whom a rhythm-control strategy is planned.

Timeline

Start
2009-03
Primary completion
2012-12
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omega-3 fatty acids Unknown 600 mg

Indications